NasdaqGM - Nasdaq Real Time Price USD
Adicet Bio, Inc. (ACET)
0.6568
-0.0112
(-1.68%)
As of 11:18:49 AM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 5 | 6 |
Avg. Estimate | -0.28 | -0.29 | -1.15 | -0.96 |
Low Estimate | -0.32 | -0.33 | -1.31 | -1.41 |
High Estimate | -0.22 | -0.22 | -0.96 | -0.73 |
Year Ago EPS | -0.33 | -0.34 | -1.33 | -1.15 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 7 | 7 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -0.37 | -0.33 | -0.35 | -0.34 |
EPS Actual | -0.33 | -0.34 | -0.32 | -0.31 |
Difference | 0.03 | -0.01 | 0.03 | 0.03 |
Surprise % | 9.59% | -2.15% | 9.86% | 7.74% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.28 | -0.29 | -1.15 | -0.96 |
7 Days Ago | -0.32 | -0.33 | -1.25 | -0.88 |
30 Days Ago | -0.32 | -0.33 | -1.25 | -0.88 |
60 Days Ago | -0.35 | -0.37 | -1.35 | -1.05 |
90 Days Ago | -0.38 | -0.4 | -1.3 | -1.1 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 4 | 2 |
Up Last 30 Days | 2 | 2 | 4 | 2 |
Down Last 7 Days | -- | -- | 1 | 2 |
Down Last 30 Days | -- | -- | 1 | 2 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ACET | 13.64% | 13.97% | 13.38% | 16.52% |
S&P 500 | 13.17% | 3.05% | 8.05% | 13.75% |
Upgrades & Downgrades
Reiterates | Guggenheim: Buy to Buy | 3/21/2025 |
Reiterates | Citizens Capital Markets: Market Perform to Market Perform | 3/7/2025 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/7/2025 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/27/2025 |
Reiterates | JMP Securities: Market Perform to Market Perform | 2/6/2025 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/5/2025 |
Related Tickers
BCYC Bicycle Therapeutics plc
8.01
-1.23%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
ALXO ALX Oncology Holdings Inc.
0.5313
+10.39%
VOR Vor Biopharma Inc.
0.1705
+6.56%
GBIO Generation Bio Co.
0.3720
-5.28%
PMVP PMV Pharmaceuticals, Inc.
0.8731
+2.45%
CRVS Corvus Pharmaceuticals, Inc.
3.6350
-6.56%
GOSS Gossamer Bio, Inc.
1.0450
-4.13%
PHAT Phathom Pharmaceuticals, Inc.
3.2500
-1.81%
XLO Xilio Therapeutics, Inc.
0.9501
-17.38%